We are live on ! Find out more
AI

Allostery Investments Portfolio holdings

AUM $7.85M
This Fund
S&P 500
This Quarter Est. Return
-14.08%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$95.7M
AUM Growth
–
Cap. Flow
+$106M
Cap. Flow %
110.83%
Top 10 Hldgs %
69.94%
Holding
40
New
40
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
EOLS icon
Evolus
EOLS
+$6.06M
2
ABVX
Abivax
ABVX
+$5.44M
3
ZURA icon
Zura Bio
ZURA
+$5.4M
4
APGE icon
Apogee Therapeutics
APGE
+$5.1M
5
KALV
KalVista Pharmaceuticals
KALV
+$4.96M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 53.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GOSS icon
26
Gossamer Bio
GOSS
$87M
$555K 0.58%
+613,028
New +$525K
DNTH icon
27
Dianthus Therapeutics
DNTH
$6.09B
$545K 0.57%
+25,000
New +$643K
AVTX icon
28
Avalo Therapeutics
AVTX
$983M
$545K 0.57%
+73,314
New +$784K
OLMA icon
29
CALL
Olema Pharmaceuticals
OLMA
$1.05B
$525K 0.55%
+90,000
New +$899K
CRNX icon
30
Crinetics Pharmaceuticals
CRNX
$8.92B
$496K 0.52%
+9,700
New +$543K
JSPR icon
31
Jasper Therapeutics
JSPR
$23.6M
$470K 0.49%
+22,000
New +$458K
PHGE icon
32
BiomX
PHGE
$1.85M
$470K 0.49%
+33,886
New +$483K
CLYM
33
Climb Bio
CLYM
$804M
$441K 0.46%
+244,988
New +$886K
ELDN icon
34
Eledon Pharmaceuticals
ELDN
$285M
$412K 0.43%
+100,000
New +$394K
ORKA
35
Oruka Therapeutics
ORKA
$5.96B
$388K 0.41%
+20,000
New +$488K
ZURA icon
36
CALL
Zura Bio
ZURA
$566M
$250K 0.26%
+100,000
New +$356K
ELEV
37
DELISTED
Elevation Oncology
ELEV
$243K 0.25%
+432,206
New +$255K
PMN icon
38
ProMIS Neurosciences
PMN
$132M
$185K 0.19%
+7,804
New +$194K
VRDN icon
39
PUT
Viridian Therapeutics
VRDN
$2.67B
$69K 0.07%
+3,600
New +$78.3K
LXEO icon
40
Lexeo Therapeutics
LXEO
$378M
$33.3K 0.03%
+5,054
New +$39.8K
1
2

Similar funds

CP
Castalian Partners Excelsior, Minnesota $7.36M AUM
CAWM
Capital A Wealth Management New Castle, Pennsylvania $8.94M AUM
ADIM
Alpha DNA Investment Management Columbia, Maryland $8.98M AUM 26.05% 1-Year Est. Return
PC
Prysm Capital Princeton, New Jersey $10.6M AUM 2.38% 1-Year Est. Return
AVM
Altos Ventures Management Burlingame, California $11.7M AUM 182.72% 1-Year Est. Return
NP
Newlight Partners New York $3.9M AUM 96.05% 1-Year Est. Return
BPWM
Black Point Wealth Management Naples, Florida $3.5M AUM 16.42% 1-Year Est. Return
CSD
Clear Street Derivatives New York $12.4M AUM 1.7% 1-Year Est. Return

Allostery Investments's Q4 2024 Portfolio in Review

Q4 2024 is the first quarter with a 13F filing on record for Allostery Investments, which disclosed 40 positions worth $95.7M. Its ten largest holdings account for 70% of the portfolio.

Its largest position is Evolus: 431,117 shares worth $4.76M.

By sector, the portfolio is most concentrated in Healthcare at 53% of assets.

  • Allostery Investments's largest Q4 2024 buy was Evolus: 431,117 shares worth $4.76M.
  • Allostery Investments's ten largest holdings make up 70% of its $95.7M portfolio in Q4 2024.
  • Allostery Investments disclosed 40 positions in Q4 2024, its first 13F filing on record.

Based on Allostery Investments's 13F filing for Q4 2024, filed 14 Feb 2025.